According to the National Rosacea Society (https://www.rosacea.org) it is estimated that Rosacea could affect as many as 415 million people globally, and many that experience Rosacea don't know they have the condition. An American national survey of those diagnosed with Rosacea found that 95% of those with Rosacea didn't know about the signs and symptoms and the links to Rosacea. The facial flushing and acne-like eruptions experienced can be associated with other dermatological conditions.
The impacts of Rosacea's symptoms can have significant impacts on quality of life with surveys from the National Rosacea Society demonstrating 90% of patients diagnosed experience lower self-esteem, 41% report they avoid social situations and 88% report it impacts their work (employment) with 51% missing days of work because of the condition. However, there are signification improvements reported in quality of life when the condition is treated (up to 70% of patients report improvement in well-being)

In 2002 a classification system was created with the 4 subtypes of Rosacea, erythematotelangiectatic, papulopustular, phymatous, and ocular rosacea. In 2017 a new classification system was published informed by 15 years of research in Rosacea to understand its pathophysiology and clinical presentations. The new system is more patient-centric based on signs and symptoms as there variation and mixed phenotypes.

Have you read this new information? You can download resources to ensure you are up to date with research and evidence-based practice in the assessment and management of Rosacea. This includes algorithms for management to assist with integrated referrals and multidisciplinary management approaches when required.